Laboratory for Immunological and Molecular Cancer Research, Third Medical Department with Hematology, Oncology, Hemostaseology, Infectiology, and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria;
Blood. 2014 Apr 3;123(14):2181-8. doi: 10.1182/blood-2013-08-523563. Epub 2014 Feb 5.
Signals from the tumor microenvironment promote the migration, survival, and proliferation of chronic lymphocytic leukemia (CLL) cells. Rho GTPases control various signaling pathways downstream of microenvironmental cues. Here, we analyze the function of Rac1 in the motility and proliferation of CLL cells. We found decreased transcription of the Rac guanine nucleotide exchange factors Tiam1 and Vav1 in unstimulated peripheral blood CLL cells with almost complete loss of Tiam1 but increased transcription of the potential Rac antagonist RhoH. Consistently, stimulation of CLL cells with the chemokine CXCL12 induced RhoA but not Rac1 activation, whereas chemokine-induced CLL cell motility was Rac1-independent. Coculture of CLL cells with activated T cells induced their activation and subsequent proliferation. Here, Tiam1 expression was induced in the malignant cells in line with increased Ki-67 and c-Myc expression. Rac1 or Tiam1 knockdown using siRNA or treatment with the Tiam1/Rac inhibitor NSC-23766 attenuated c-Myc transcription. Furthermore, treatment of CLL cells with NSC-23766 reduced their proliferation. Rac inhibition also antagonized the chemoresistance of activated CLL cells toward fludarabine. Collectively, our data suggest a dynamic regulation of Rac1 function in the CLL microenvironment. Rac inhibition could be of clinical use by selectively interfering with CLL cell proliferation and chemoresistance.
肿瘤微环境中的信号促进慢性淋巴细胞白血病(CLL)细胞的迁移、存活和增殖。Rho GTPases 控制微环境线索下游的各种信号通路。在这里,我们分析了 Rac1 在 CLL 细胞迁移和增殖中的功能。我们发现未刺激的外周血 CLL 细胞中 Rac 鸟嘌呤核苷酸交换因子 Tiam1 和 Vav1 的转录减少,几乎完全丧失了 Tiam1,但潜在的 Rac 拮抗剂 RhoH 的转录增加。一致地,趋化因子 CXCL12 刺激 CLL 细胞诱导 RhoA 但不诱导 Rac1 激活,而趋化因子诱导的 CLL 细胞迁移是 Rac1 非依赖性的。CLL 细胞与激活的 T 细胞共培养诱导其激活和随后的增殖。在这里,恶性细胞中的 Tiam1 表达与 Ki-67 和 c-Myc 表达的增加一致诱导。使用 siRNA 或 Tiam1/Rac 抑制剂 NSC-23766 进行 Rac1 或 Tiam1 敲低减弱了 c-Myc 转录。此外,用 NSC-23766 处理 CLL 细胞可降低其增殖。 Rac 抑制还拮抗了激活的 CLL 细胞对氟达拉滨的耐药性。总之,我们的数据表明 Rac1 功能在 CLL 微环境中存在动态调节。Rac 抑制通过选择性干扰 CLL 细胞增殖和化疗耐药性,可能具有临床应用价值。